Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-000294-78Phase 2Terminated
Phase 2, randomised, single-blind trial in onychomycosis comparing Mycosinate arm with Curanail arm (2 arms). Primary endpoint: Viability of the infection. Started Jul 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-000294-78.